Amedeo Smart

Free Medical Literature Service

 

Amedeo

Neoplasms of the CNS
  Free Subscription

Articles published in
J Neurosurg
    April 2024
  1. ALMAIRAC F, Parker D, Mondot L, Isan P, et al
    Improvement of diffusion tensor imaging-based tractography by free-water correction in nonedematous gliomas: assessment with brain mapping.
    J Neurosurg. 2024 Apr 19:1-11. doi: 10.3171/2024.1.JNS23568.
    >> Share

  2. AMIRJAMSHIDI A, Abbasioun K
    Letter to the Editor. Spheno-orbital meningioma.
    J Neurosurg. 2024 Apr 19:1. doi: 10.3171/2024.1.JNS2491.
    >> Share

  3. PLANTY-BONJOUR A, Terrier LM, Cognacq G, Aggad M, et al
    Bilateral spheno-orbital meningiomas: surgical management, progression, and recurrence.
    J Neurosurg. 2024 Apr 19:1-9. doi: 10.3171/2024.1.JNS232406.
    >> Share

  4. QI Y, Xu Y, Yan T, Xiong W, et al
    Use of circulating tumor cells and microemboli to predict diagnosis and prognosis in diffuse glioma.
    J Neurosurg. 2024 Apr 12:1-11. doi: 10.3171/2024.1.JNS232020.
    >> Share

  5. ASFAW ZK, Hernandez-Marquez GC, Naik A, Young T, et al
    The intersection of race and social determinants of health on clinical outcome of glioblastoma patients.
    J Neurosurg. 2024 Apr 5:1-10. doi: 10.3171/2024.1.JNS232702.
    >> Share

  6. MERENZON MA, Mendez Valdez MJ, Chandar J, Lu VM, et al
    Minimally invasive keyhole approach for supramaximal frontal glioma resections: technical note.
    J Neurosurg. 2023;140:949-957.
    >> Share

  7. LUCIDO T, Rajkumar S, Rogowski B, Meinert J, et al
    The 5-factor modified frailty index as a prognostic factor of stereotactic radiosurgery for metastatic disease to the brain.
    J Neurosurg. 2023;140:929-937.
    >> Share

  8. ZHANG S, Yao S, Chen J, Akter F, et al
    Correlation between tumor invasion and somatostatin receptor subtypes in acromegaly.
    J Neurosurg. 2023;140:1019-1028.
    >> Share

    March 2024
  9. MAKARENKO S
    Erratum. Grade 3 meningioma survival and recurrence outcomes in an international multicenter cohort.
    J Neurosurg. 2024 Mar 29:1. doi: 10.3171/2024.2.JNS23465.
    >> Share

  10. KONECNA D, Vymola P, Ternerova N, Vymolova B, et al
    Molecularly targeted protease-activated probes for visualization of glioblastoma: a comparison with 5-ALA.
    J Neurosurg. 2024 Mar 29:1-12. doi: 10.3171/2024.1.JNS231137.
    >> Share

  11. REN L, Xie Q, Deng J, Chen J, et al
    Association of frequent NF2 mutations with spinal location predominance and worse outcomes in psammomatous meningiomas.
    J Neurosurg. 2024 Mar 29:1-9. doi: 10.3171/2024.1.JNS232450.
    >> Share

  12. TABOR JK, Dincer A, O'Brien J, Lei H, et al
    Variations in the genomic profiles and clinical behavior of meningioma by racial and ethnic group.
    J Neurosurg. 2024 Mar 22:1-9. doi: 10.3171/2024.1.JNS231633.
    >> Share

  13. CHIANG VL, Pugazenthi S, Leidig WA, Rodriguez A, et al
    Laser interstitial thermal therapy for new and recurrent meningioma: a prospective and retrospective case series.
    J Neurosurg. 2024 Mar 8:1-11. doi: 10.3171/2023.12.JNS231542.
    >> Share

  14. OHTSUKA Y, Suehiro S, Inoue A, Ohnishi T, et al
    Berberine as a potential enhancer for 5-ALA-mediated fluorescence in glioblastoma: increasing detectability of infiltrating glioma stem cells to optimize 5-ALA-guided surgery.
    J Neurosurg. 2024 Mar 8:1-11. doi: 10.3171/2023.12.JNS231506.
    >> Share

  15. COTE DJ, Kruchko C, Barnholtz-Sloan JS, Zada G, et al
    Association between county-level socioeconomic status and the incidence of and surgical treatment for pituitary adenoma.
    J Neurosurg. 2023;140:724-734.
    >> Share

  16. OSORIO RC, Haddad AF, Hart DM, Goldrich N, et al
    Socioeconomic differences between medically and surgically treated prolactinomas: a retrospective review of 598 patients.
    J Neurosurg. 2023;140:712-723.
    >> Share

    February 2024
  17. SAMANCI Y, Peker S
    Letter to the Editor. Anterior clinoid meningioma and radiosurgery.
    J Neurosurg. 2024 Feb 16:1-2. doi: 10.3171/2023.12.JNS232820.
    >> Share

  18. SAWAYA R, Yamaguchi S, Ishi Y, Okamoto M, et al
    Increased CD44 expression in primary meningioma: its clinical significance and association with peritumoral brain edema.
    J Neurosurg. 2024 Feb 9:1-8. doi: 10.3171/2023.11.JNS231884.
    >> Share

  19. ABDULLAHI H
    Letter to the Editor. The association between metastatic brain tumors and brain tumor-related epilepsy.
    J Neurosurg. 2024 Feb 2:1-2. doi: 10.3171/2023.11.JNS232526.
    >> Share

  20. CARRETE LR, Morshed RA, Young JS, Avalos LN, et al
    Analysis of upfront resection or stereotactic radiosurgery for local control of solid and cystic cerebellar hemangioblastomas.
    J Neurosurg. 2023;140:404-411.
    >> Share

    January 2024
  21. HUA L, Alkhatib M, Fujio S, Alhasan B, et al
    Genetic characterization and mutational profiling of foramen magnum meningiomas: a multi-institutional study.
    J Neurosurg. 2024 Jan 26:1-7. doi: 10.3171/2023.11.JNS231936.
    >> Share

  22. KHAZANCHI R, Nandoliya KR, Shahin MN, Rae AI, et al
    Obesity and meningioma: a US population-based study paired with analysis of a multi-institutional cohort.
    J Neurosurg. 2024 Jan 19:1-10. doi: 10.3171/2023.11.JNS23732.
    >> Share

  23. SAUVAGEOT S, Mollevi C, Thomas QD, Charissoux M, et al
    Prognostic impact of the number and total tumor burden of secondary cerebral lesions in patients with resected brain metastases of non-small cell lung cancers.
    J Neurosurg. 2024 Jan 19:1-11. doi: 10.3171/2023.11.JNS231923.
    >> Share

  24. HOSSAIN-IBRAHIM MK
    Letter to the Editor. ALA in the treatment of glioblastoma.
    J Neurosurg. 2024 Jan 19:1-2. doi: 10.3171/2023.11.JNS232472.
    >> Share

  25. CHALIF EJ, Young JS, Villa GR, Aghi MK, et al
    High-volume facilities are not always low risk: comparing risk-standardized mortality rates versus facility volume as quality measures in surgical neuro-oncology.
    J Neurosurg. 2023;140:10-17.
    >> Share

  26. LIU Y, Gao D, Chen H, Zhang J, et al
    IDH-mutant grade 4 astrocytoma: a comparison integrating the clinical, pathological, and survival features between primary and secondary patients.
    J Neurosurg. 2023;140:94-103.
    >> Share

  27. HIRANO Y, Shojima M, Uno T, Koizumi S, et al
    Custom shaping of distal access catheter for navigation of microcatheter into inferolateral and meningohypophyseal trunk feeders.
    J Neurosurg. 2023;140:194-200.
    >> Share

  28. WU Y, Zhao T, Cai Y, Zheng M, et al
    Clinical outcomes of solitary fibrous tumors and hemangiopericytomas and risk factors related to recurrence and survival based on the 2021 WHO classification of central nervous system tumors.
    J Neurosurg. 2023;140:69-79.
    >> Share

    December 2023
  29. GRUTZA M, Dao Trong P, Zweckberger K, Unterberg A, et al
    Pterional approach for tuberculum sellae meningiomas: a 17-year single-center experience.
    J Neurosurg. 2023 Dec 15:1-8. doi: 10.3171/2023.9.JNS231657.
    >> Share

  30. BANDER ED, Pandey A, Yan J, Giantini-Larsen AM, et al
    Olfactory groove meningiomas: supraorbital keyhole versus orbitofrontal, frontotemporal, or bifrontal approaches.
    J Neurosurg. 2023 Dec 8:1-8. doi: 10.3171/2023.10.JNS231432.
    >> Share

  31. CATAPANO JS, Rumalla K, Srinivasan VM, Benner D, et al
    A taxonomy for deep cerebral cavernous malformations: subtypes of thalamic lesions.
    J Neurosurg. 2023;139:1681-1696.
    >> Share

    November 2023
  32. VAZQUEZ S, Gold J, Spirollari E, Akmal S, et al
    The story of dexamethasone and how it became one of the most widely used drugs in neurosurgery.
    J Neurosurg. 2023 Nov 24:1-7. doi: 10.3171/2023.9.JNS231099.
    >> Share

  33. MURAYI R, El-Abtah M, Xiao T, Recinos PF, et al
    Orbital reconstruction and volume in the correction of proptosis after resection of spheno-orbital meningiomas.
    J Neurosurg. 2023 Nov 17:1-7. doi: 10.3171/2023.8.JNS23305.
    >> Share

  34. TAO X, Fan X, Gui S, Liu J, et al
    Efficacy of intraoperative visual evoked potential amplitude reduction in predicting visual outcome after extended endoscopic endonasal resection of craniopharyngiomas.
    J Neurosurg. 2023 Nov 10:1-6. doi: 10.3171/2023.9.JNS23457.
    >> Share

  35. DAMANTE MA, Magill ST, Kreatsoulas D, McGahan BG, et al
    A modern approach to olfactory groove meningiomas.
    J Neurosurg. 2023 Nov 10:1-8. doi: 10.3171/2023.8.JNS2318.
    >> Share

  36. MICHALOPOULOS GD, Katsos K, Grills IS, Warnick RE, et al
    Stereotactic radiosurgery in the management of non-small cell lung cancer brain metastases: a prospective study using the NeuroPoint Alliance Stereotactic Radiosurgery Registry.
    J Neurosurg. 2023 Nov 10:1-10. doi: 10.3171/2023.8.JNS23308.
    >> Share

  37. BIN-ALAMER O, Abou-Al-Shaar H, Singh R, Mallela AN, et al
    Local control and survival after stereotactic radiosurgery for colorectal cancer brain metastases: an international multicenter analysis.
    J Neurosurg. 2023 Nov 10:1-10. doi: 10.3171/2023.8.JNS231231.
    >> Share

  38. PASCUAL JM, Prieto R
    Letter to the Editor. Infundibulotuberal craniopharyngiomas: the high-risk category that must be defined.
    J Neurosurg. 2023 Nov 3:1-2. doi: 10.3171/2023.8.JNS231836.
    >> Share

  39. COHEN-COHEN S, Graffeo CS, Botello-Hernandez E, Carlstrom LP, et al
    Anterior clinoid meningiomas: surgical results and proposed scoring system to predict visual outcomes.
    J Neurosurg. 2023 Nov 3:1-10. doi: 10.3171/2023.8.JNS23894.
    >> Share

  40. ASMARO K, Zhang M, Rodrigues AJ, Mohyeldin A, et al
    Cytodifferentiation of pituitary tumors influences pathogenesis and cavernous sinus invasion.
    J Neurosurg. 2023;139:1216-1224.
    >> Share

  41. CAULLEY L, Dijk SW, Krijkamp E, Dong SX, et al
    Cost-effectiveness of postoperative imaging surveillance strategies for nonfunctional pituitary adenomas after resection with curative intent.
    J Neurosurg. 2023;139:1207-1215.
    >> Share

    October 2023
  42. MORSHED RA, Cummins DD, Clark JP, Young JS, et al
    Asleep triple-modality motor mapping for perirolandic gliomas: an update on outcomes.
    J Neurosurg. 2023 Oct 13:1-9. doi: 10.3171/2023.8.JNS231036.
    >> Share

  43. PICART T, Pallud J, Berthiller J, Dumot C, et al
    Use of 5-ALA fluorescence-guided surgery versus white-light conventional microsurgery for the resection of newly diagnosed glioblastomas (RESECT study): a French multicenter randomized phase III study.
    J Neurosurg. 2023 Oct 13:1-14. doi: 10.3171/2023.7.JNS231170.
    >> Share

  44. NGUYEN A, Brown NJ, Gendreau J, Nguyen BA, et al
    The association of thromboembolic complications and the use of tranexamic acid during resection of intracranial meningiomas: systematic review and meta-analysis of randomized controlled trials.
    J Neurosurg. 2023 Oct 6:1-11. doi: 10.3171/2023.7.JNS23849.
    >> Share

  45. HOZ SS, Palmisciano P, Albairmani SS, Kaye J, et al
    A proposed classification system for presigmoid approaches: a scoping review.
    J Neurosurg. 2023;139:965-971.
    >> Share

  46. MILLER MS, Kim W, Harary M, Savjani RR, et al
    Seizure outcomes following single-fraction versus hypofractionated radiosurgery for brain metastases: a single-center experience.
    J Neurosurg. 2023;139:925-933.
    >> Share

  47. FLOREA SM, Passeri T, Abbritti R, Bernat AL, et al
    Opposed evolution of the osseous and soft parts of progestin-associated osteomeningioma after progestin intake discontinuation.
    J Neurosurg. 2023;139:944-952.
    >> Share

    September 2023
  48. BOVE I, Solari D, Colangelo M, Fabozzi GL, et al
    Analysis of visual impairment score in a series of 48 tuberculum sellae meningiomas operated on via the endoscopic endonasal approach.
    J Neurosurg. 2023 Sep 29:1-9. doi: 10.3171/2023.7.JNS23437.
    >> Share

  49. HONG S, Bouchal SM, Bauman MMJ, Riviere-Cazaux C, et al
    The longitudinal risk of hemorrhage of melanoma brain metastases after Gamma Knife radiosurgery.
    J Neurosurg. 2023 Sep 29:1-11. doi: 10.3171/2023.7.JNS231225.
    >> Share

  50. LIU Z, Mela A, Argenziano MG, Banu MA, et al
    Single-cell analysis of 5-aminolevulinic acid intraoperative labeling specificity for glioblastoma.
    J Neurosurg. 2023 Sep 22:1-11. doi: 10.3171/2023.7.JNS23122.
    >> Share

  51. ANDREWS JP, Cummins DD, Morshed RA, Kinde B, et al
    Intraventricular meningioma resection and visual outcomes.
    J Neurosurg. 2023 Sep 22:1-7. doi: 10.3171/2023.7.JNS23680.
    >> Share

  52. LAVRADOR JP, Hodgkinson S, Knight J, Patel S, et al
    Nonenhancing motor eloquent gliomas: navigated transcranial magnetic stimulation oncobiological signature.
    J Neurosurg. 2023 Sep 15:1-11. doi: 10.3171/2023.6.JNS222443.
    >> Share

  53. HIGGINS JNP, Kirollos SRW, Helmy A, Guilfoyle MR, et al
    Technical considerations and long-term results of endovascular venous stenting to control venous hypertension from meningiomas invading intracranial venous sinuses.
    J Neurosurg. 2023 Sep 8:1-13. doi: 10.3171/2023.6.JNS23607.
    >> Share

  54. MUSCA B, Bonaudo C, Tushe A, Battaggia G, et al
    Sodium fluorescein uptake by the tumor microenvironment in human gliomas and brain metastases.
    J Neurosurg. 2023 Sep 1:1-10. doi: 10.3171/2023.7.JNS23873.
    >> Share

  55. ALEXANDRATOU A, Virjee RI, Ghare A, Sefcikova V, et al
    Intraoperative stimulation mapping of thalamocortical tracts in asleep and awake settings: novel electrophysiological, anatomical, and tractographic paradigms.
    J Neurosurg. 2023;139:873-880.
    >> Share

  56. WANG W, He H, Zeng S, Cho HY, et al
    Enhanced brain entry of checkpoint-inhibitory therapeutic antibodies facilitated by intraarterial NEO100 in mouse models of brain-localized malignancies.
    J Neurosurg. 2023;139:822-830.
    >> Share

  57. TANG H, Wang X, Bie Z, Yang Z, et al
    Pituitary adenomas with multiple cell lineage combinations: clinicopathological features and short-term prognosis.
    J Neurosurg. 2023;139:810-821.
    >> Share

    August 2023
  58. BROWN NJ, Gendreau J, Chakravarti S, Abraham BM, et al
    The influence of facility type on intracranial meningioma treatment and outcomes: predicting overall survival using the National Cancer Database.
    J Neurosurg. 2023 Aug 18:1-7. doi: 10.3171/2023.6.JNS231145.
    >> Share

  59. ZHANG R, Wang Z, Zheng H, Chen X, et al
    The value of diffusion-weighted imaging in the natural history of meningiomas: a predictor of tumor growth.
    J Neurosurg. 2023 Aug 18:1-9. doi: 10.3171/2023.6.JNS222483.
    >> Share

  60. TOSEFSKY K, Rebchuk AD, Wang JZ, Ellenbogen Y, et al
    Grade 3 meningioma survival and recurrence outcomes in an international multicenter cohort.
    J Neurosurg. 2023 Aug 11:1-11. doi: 10.3171/2023.6.JNS23465.
    >> Share

  61. GIANTINI-LARSEN AM, Abou-Mrad Z, Yu KK, Reiner AS, et al
    Treatment and outcomes of IDH1-mutant gliomas in elderly patients.
    J Neurosurg. 2023 Aug 11:1-10. doi: 10.3171/2023.6.JNS222907.
    >> Share

  62. DUFFAU H
    Damaging a few millimeters of the deep white matter tracts during glioma surgery may result in a large-scale brain disconnection.
    J Neurosurg. 2023 Aug 11:1-4. doi: 10.3171/2023.6.JNS231048.
    >> Share

  63. MARTINI ML, Ransom RC, Rechberger JS, O'Keeffe D, et al
    Angiographic cross-filling between inferior petrosal sinuses and alteration of adrenocorticotropic hormone sampling results for tumor localization in Cushing disease.
    J Neurosurg. 2023 Aug 11:1-7. doi: 10.3171/2023.6.JNS2320.
    >> Share

  64. KIM JH, Hong CK, Shin HJ, Kong DS, et al
    Feasibility and efficacy of endoscopic transorbital optic canal decompression for meningiomas causing compressive optic neuropathy.
    J Neurosurg. 2023 Aug 4:1-8. doi: 10.3171/2023.5.JNS2326.
    >> Share

  65. XU Y, Mathis AM, Pollo B, Schlegel J, et al
    Intraoperative in vivo confocal laser endomicroscopy imaging at glioma margins: can we detect tumor infiltration?
    J Neurosurg. 2023 Aug 4:1-10. doi: 10.3171/2023.5.JNS23546.
    >> Share

  66. HALLAK H, Rindler R, Dang D, Abou-Al-Shaar H, et al
    Trigeminal neuralgia pain outcomes following microsurgical resection versus stereotactic radiosurgery for petroclival meningiomas: a systematic review and meta-analysis.
    J Neurosurg. 2023 Aug 4:1-10. doi: 10.3171/2023.5.JNS222557.
    >> Share

  67. SANVITO F, Telesca D, Cho NS, Sayari JT, et al
    Small pretreatment lesion size and high sphericity as favorable prognostic factors after laser interstitial thermal therapy in brain metastases.
    J Neurosurg. 2023 Aug 4:1-12. doi: 10.3171/2023.5.JNS23285.
    >> Share

    July 2023
  68. MORSHED RA, Cummins DD, Nguyen MP, Saggi S, et al
    Genomic alterations associated with postoperative nodular leptomeningeal disease after resection of brain metastases.
    J Neurosurg. 2023 Jul 28:1-10. doi: 10.3171/2023.5.JNS23460.
    >> Share

  69. ZANELLO M, Debacker C, Moiraghi A, Peeters S, et al
    Use of MR signal intensity variations to highlight structures at risk along brain biopsy trajectories.
    J Neurosurg. 2023 Jul 28:1-11. doi: 10.3171/2023.5.JNS23263.
    >> Share

  70. SERRA C, Ture H, Firat Z, Staartjes VE, et al
    Microsurgical management of midbrain gliomas: surgical results and long-term outcome in a large, single-surgeon, consecutive series.
    J Neurosurg. 2023 Jul 21:1-12. doi: 10.3171/2023.5.JNS222219.
    >> Share

  71. TONG L, Medeiros L, Moen EL, Dhand A, et al
    Dissecting patterns and predictors of interhospital transfers for patients with brain metastasis.
    J Neurosurg. 2023 Jul 14:1-11. doi: 10.3171/2023.5.JNS222922.
    >> Share

  72. CATALINO MP, Noll KR, Wefel JS, Michener H, et al
    Decoding the clinical effects of low-grade glioma-induced cortical excitability.
    J Neurosurg. 2023 Jul 7:1-9. doi: 10.3171/2023.5.JNS23747.
    >> Share

    June 2023
  73. CARNEVALE JA, Pandey A, Ramirez-Loera C, Goldberg JL, et al
    Endonasal, supraorbital, and transorbital approaches: minimal access endoscope-assisted surgical approaches for meningiomas in the anterior and middle cranial fossae.
    J Neurosurg. 2023 Jun 30:1-9. doi: 10.3171/2023.5.JNS23103.
    >> Share

  74. QIAO N, Li C, Liu F, Ru S, et al
    Risk factors for cerebrospinal fluid leak after extended endoscopic endonasal surgery for adult patients with craniopharyngiomas: a multivariate analysis of 364 cases.
    J Neurosurg. 2023 Jun 23:1-12. doi: 10.3171/2023.5.JNS222791.
    >> Share

  75. YOUNG JS, Al-Adli NN, Muster R, Chandra A, et al
    Does waiting for surgery matter? How time from diagnostic MRI to resection affects outcomes in newly diagnosed glioblastoma.
    J Neurosurg. 2023 Jun 23:1-14. doi: 10.3171/2023.5.JNS23388.
    >> Share

  76. HONG CS, Lamsam LA, Yadlapalli V, Parasuram N, et al
    Portable MRI to assess optic chiasm decompression after endoscopic endonasal resection of sellar and suprasellar lesions.
    J Neurosurg. 2023 Jun 16:1-7. doi: 10.3171/2023.5.JNS23174.
    >> Share

  77. VOOIJS M, Robertson FC, Rosseau G, Tasiou A, et al
    Ethical challenges of travel for experimental therapy in malignant brain tumor patients.
    J Neurosurg. 2023 Jun 2:1-5. doi: 10.3171/2023.4.JNS2369.
    >> Share

    May 2023
  78. MIYAGISHIMA DF, Sundaresan V, Gutierrez AG, Barak T, et al
    A systematic review and individual participant data meta-analysis of gonadal steroid hormone receptors in meningioma.
    J Neurosurg. 2023 May 26:1-10. doi: 10.3171/2023.3.JNS221838.
    >> Share

  79. LIM-FAT MJ, Das S
    Unique molecular, clinical, and treatment aspects of gliomas in adolescents and young adults: a review.
    J Neurosurg. 2023 May 26:1-9. doi: 10.3171/2023.4.JNS221800.
    >> Share

  80. YOMO S, Oda K, Oguchi K
    Synergistic effects of immune checkpoint inhibitors in combination with stereotactic radiosurgery for patients with lung cancer and brain metastases: a propensity score-matched analysis.
    J Neurosurg. 2023 May 26:1-10. doi: 10.3171/2023.4.JNS2349.
    >> Share

  81. TABOR JK, O'Brien J, Vasandani S, Vetsa S, et al
    Clinical and genomic differences in supratentorial versus infratentorial NF2 mutant meningiomas.
    J Neurosurg. 2023 May 26:1-9. doi: 10.3171/2023.4.JNS222929.
    >> Share

  82. MACARTHUR JI, O'Brien F, Hannan CJ, Hammerbeck-Ward C, et al
    Does tumoral cavernous carotid stenosis predict an increased risk of future stroke in skull base meningiomas?
    J Neurosurg. 2023 May 12:1-6. doi: 10.3171/2023.4.JNS23378.
    >> Share

  83. FANG S, Weng S, Li L, Guo Y, et al
    Association of homotopic areas in the right hemisphere with language deficits in the short term after tumor resection.
    J Neurosurg. 2022;138:1206-1215.
    >> Share

  84. RIVA M, Wilson SM, Cai R, Castellano A, et al
    Evaluating syntactic comprehension during awake intraoperative cortical stimulation mapping.
    J Neurosurg. 2022;138:1403-1410.
    >> Share

  85. KINOSHITA Y, Taguchi A, Yamasaki F, Tominaga A, et al
    Natural course of Rathke's cleft cysts and risk factors for progression.
    J Neurosurg. 2022;138:1426-1432.
    >> Share

    April 2023
  86. SADHASIVAM S, Menon G, Abraham M, Arora RK, et al
    The influence of tumor topography on the surgical outcome of craniopharyngiomas.
    J Neurosurg. 2023 Apr 28:1-11. doi: 10.3171/2023.3.JNS222302.
    >> Share

  87. BOBEFF EJ, Mathios D, Mistry AA, Dobri GA, et al
    Predictors of extent of resection and recurrence following endoscopic endonasal resection of craniopharyngioma.
    J Neurosurg. 2023 Apr 28:1-12. doi: 10.3171/2023.3.JNS222607.
    >> Share

  88. PASCUAL JM, Prieto R, Rosdolsky M, Hofecker V, et al
    Anton de Haen (1704-1776) and his extraordinary "portentosum infundibulum" case: the futile skull cauterization of a blind patient with a craniopharyngioma.
    J Neurosurg. 2023 Apr 28:1-10. doi: 10.3171/2023.3.JNS2381.
    >> Share

  89. LUCKETT PH, Park KY, Lee JJ, Lenze EJ, et al
    Data-efficient resting-state functional magnetic resonance imaging brain mapping with deep learning.
    J Neurosurg. 2023 Apr 14:1-12. doi: 10.3171/2023.3.JNS2314.
    >> Share

    March 2023
  90. LI HY, Ying YZ, Zheng D, Dong GH, et al
    Is brain invasion sufficient as a stand-alone criterion for grading atypical meningioma?
    J Neurosurg. 2023 Mar 31:1-12. doi: 10.3171/2023.2.JNS222751.
    >> Share

  91. SAUVAGEOT S, Boetto J, Duffau H
    Surgical, functional, and oncological considerations regarding awake resection for giant diffuse lower-grade glioma of more than 100 cm3.
    J Neurosurg. 2023 Mar 24:1-10. doi: 10.3171/2023.2.JNS222755.
    >> Share

  92. ZHAO B, Ma W
    Letter to the Editor. Acoustic analysis during glioma surgery.
    J Neurosurg. 2023 Mar 3:1. doi: 10.3171/2023.1.JNS2395.
    >> Share

  93. TRAYLOR JI, Plitt AR, Hicks WH, Mian TM, et al
    Evaluating risk of recurrence in patients with meningioma.
    J Neurosurg. 2022;138:621-628.
    >> Share

  94. YAN M, Holden L, Detsky J, Tseng CL, et al
    Conventionally fully fractionated Gamma Knife Icon re-irradiation of primary recurrent intracranial tumors: the first report indicating feasibility and safety.
    J Neurosurg. 2022;138:674-682.
    >> Share

    February 2023
  95. SCHUPPER AJ, Hadjipanayis CG
    Novel approaches to targeting gliomas at the leading/cutting edge.
    J Neurosurg. 2023 Feb 24:1-9. doi: 10.3171/2023.1.JNS221798.
    >> Share

  96. EL-SHEHABY AMN, Reda WA, Abdel Karim KM, Nabeel AM, et al
    Single-session stereotactic radiosurgery for large perioptic meningiomas.
    J Neurosurg. 2023 Feb 17:1-10. doi: 10.3171/2023.1.JNS221951.
    >> Share

  97. YOUNG JS, Al-Adli N, Scotford K, Cha S, et al
    Pseudoprogression versus true progression in glioblastoma: what neurosurgeons need to know.
    J Neurosurg. 2023 Feb 10:1-12. doi: 10.3171/2022.12.JNS222173.
    >> Share

  98. LOPEZ DC, Almeida JP, Momin AA, Andrade EJ, et al
    Triphasic response after endoscopic craniopharyngioma resection and its dependency on infundibular preservation or sacrifice.
    J Neurosurg. 2023 Feb 3:1-8. doi: 10.3171/2022.12.JNS221137.
    >> Share

  99. RUBINO F, Schur S, McGovern SL, Kamiya-Matsuoka C, et al
    Impact of salvage surgery with or without reirradiation for skull base meningiomas recurring after prior radiotherapy.
    J Neurosurg. 2023 Feb 3:1-12. doi: 10.3171/2022.12.JNS222010.
    >> Share

  100. BIANCO A, Del Maestro M, Fanti A, Airoldi C, et al
    Use of fluorescein sodium-assisted intraoperative sample validation to maximize the diagnostic yield of stereotactic brain biopsy: progress toward a new standard of care?
    J Neurosurg. 2022;138:358-366.
    >> Share

  101. CASTLE-KIRSZBAUM M, Wang YY, King J, Kam J, et al
    Quality of life and surgical outcomes in incidental pituitary adenomas undergoing endoscopic endonasal resection.
    J Neurosurg. 2022;138:567-573.
    >> Share

    January 2023
  102. IWAHASHI H, Nagashima H, Tanaka K, Uno T, et al
    2-Hydroxyglutarate magnetic resonance spectroscopy in adult brainstem glioma.
    J Neurosurg. 2023 Jan 27:1-8. doi: 10.3171/2022.12.JNS221954.
    >> Share

  103. PRZYBYLOWSKI CJ, Suki D, Raza SM, DeMonte F, et al
    Volumetric extent of resection and survival for recurrent atypical meningioma.
    J Neurosurg. 2023 Jan 27:1-11. doi: 10.3171/2022.12.JNS221815.
    >> Share

  104. MURAGAKI Y, Ishikawa E, Maruyama T, Nitta M, et al
    A multicenter, randomized, placebo-controlled phase IIb trial of an autologous formalin-fixed tumor vaccine for newly diagnosed glioblastomas.
    J Neurosurg. 2023 Jan 20:1-11. doi: 10.3171/2022.12.JNS221221.
    >> Share

  105. MORSHED RA, Saggi S, Cummins DD, Molinaro AM, et al
    Identification of risk factors associated with leptomeningeal disease after resection of brain metastases.
    J Neurosurg. 2023 Jan 13:1-12. doi: 10.3171/2022.12.JNS221490.
    >> Share

  106. GIAMMATTEI L, Passeri T, Abbritti R, Lieber S, et al
    Surgical morbidity of the extradural anterior petrosal approach: the Lariboisiere experience.
    J Neurosurg. 2022;138:276-286.
    >> Share

  107. ICHIMASU N, Kohno M, Nakajima N, Sakamoto H, et al
    Features of postoperative hearing function changes in patients with cerebellopontine angle and intratemporal tumors other than vestibular schwannomas.
    J Neurosurg. 2022;138:78-85.
    >> Share

    December 2022
  108. CATALINO MP, Buss E, Chamberlin G, Trembath D, et al
    Tumor sound, auditory cues, and tissue pathology in glioma surgery: a proof-of-concept study.
    J Neurosurg. 2022 Dec 30:1-9. doi: 10.3171/2022.11.JNS222114.
    >> Share

  109. HERTA J, Cho A, Roetzer-Pejrimovsky T, Hoftberger R, et al
    Optimizing maximum resection of glioblastoma: Raman spectroscopy versus 5-aminolevulinic acid.
    J Neurosurg. 2022 Dec 23:1-10. doi: 10.3171/2022.11.JNS22693.
    >> Share

  110. LV K, Chen H, Cao X, Du P, et al
    Development and validation of a machine learning algorithm for predicting diffuse midline glioma, H3 K27-altered, H3 K27 wild-type high-grade glioma, and primary CNS lymphoma of the brain midline in adults.
    J Neurosurg. 2022 Dec 23:1-9. doi: 10.3171/2022.11.JNS221544.
    >> Share

  111. CHIANG CL, Yang HC, Luo YH, Chen CJ, et al
    Leptomeningeal metastasis in patients with non-small cell lung cancer after stereotactic radiosurgery for brain metastasis.
    J Neurosurg. 2022 Dec 9:1-8. doi: 10.3171/2022.11.JNS221888.
    >> Share

  112. SHASBY G
    Erratum. Association of the FGFR1 mutation with spontaneous hemorrhage in low-grade gliomas in pediatric and young adult patients.
    J Neurosurg. 2022 Dec 9:1. doi: 10.3171/2022.11.JNS192155.
    >> Share

  113. ZHONG S, Ren JX, Yu ZP, Peng YD, et al
    Predicting glioblastoma molecular subtypes and prognosis with a multimodal model integrating convolutional neural network, radiomics, and semantics.
    J Neurosurg. 2022 Dec 2:1-10. doi: 10.3171/2022.10.JNS22801.
    >> Share

  114. YUAN Q, Yao HJ, Xi CH, Yu C, et al
    Perioperative risk factors associated with unplanned neurological intensive care unit readmission following elective supratentorial brain tumor resection.
    J Neurosurg. 2022 Dec 2:1-9. doi: 10.3171/2022.10.JNS221318.
    >> Share

  115. TUNCER MS, Fekonja LS, Ott S, Pfnur A, et al
    Role of interhemispheric connectivity in recovery from postoperative supplementary motor area syndrome in glioma patients.
    J Neurosurg. 2022 Dec 2:1-10. doi: 10.3171/2022.10.JNS221303.
    >> Share

  116. CHALIF EJ, Morshed RA, Young JS, Haddad AF, et al
    Pituitary adenoma in the elderly: surgical outcomes and treatment trends in the United States.
    J Neurosurg. 2022;137:1687-1698.
    >> Share

  117. DASHTI SR, Kadner RJ, Folley BS, Sheehan JP, et al
    Single low-dose targeted bevacizumab infusion in adult patients with steroid-refractory radiation necrosis of the brain: a phase II open-label prospective clinical trial.
    J Neurosurg. 2022;137:1676-1686.
    >> Share

  118. COTE DJ, Ruzevick JJ, Kang KM, Pangal DJ, et al
    Association between socioeconomic status and presenting characteristics and extent of disease in patients with surgically resected nonfunctioning pituitary adenoma.
    J Neurosurg. 2022;137:1699-1706.
    >> Share

    November 2022
  119. KOWALCHUK RO, Niranjan A, Hess J, Antonios JP, et al
    Stereotactic radiosurgery and local control of brain metastases from triple-negative breast cancer.
    J Neurosurg. 2022 Nov 25:1-7. doi: 10.3171/2022.10.JNS221900.
    >> Share

  120. QUINONES A, Jenabi M, Pasquini L, Peck KK, et al
    Use of longitudinal functional MRI to demonstrate translocation of language function in patients with brain tumors.
    J Neurosurg. 2022 Nov 25:1-9. doi: 10.3171/2022.10.JNS221212.
    >> Share

  121. MUIR M, Gadot R, Prinsloo S, Michener H, et al
    Comparative study of preoperative functional imaging combined with tractography for prediction of iatrogenic motor deficits.
    J Neurosurg. 2022 Nov 25:1-8. doi: 10.3171/2022.10.JNS221684.
    >> Share

  122. SASAKI T, Watanabe J, He X, Katagi H, et al
    Intranasal delivery of nanoliposomal SN-38 for treatment of diffuse midline glioma.
    J Neurosurg. 2022 Nov 11:1-10. doi: 10.3171/2022.9.JNS22715.
    >> Share

  123. KOFOED LAURIDSEN E, Ciochon UM, Tolver A, Bech Knudsen M, et al
    Long-term postoperative health-related quality of life in patients with subfrontal meningiomas.
    J Neurosurg. 2022 Nov 11:1-10. doi: 10.3171/2022.9.JNS22826.
    >> Share

  124. DOHM AE, Tang JD, Mills MN, Liveringhouse CL, et al
    Clinical outcomes of non-small cell lung cancer brain metastases treated with stereotactic radiosurgery and immune checkpoint inhibitors, EGFR tyrosine kinase inhibitors, chemotherapy and immune checkpoint inhibitors, or chemotherapy alone.
    J Neurosurg. 2022 Nov 11:1-8. doi: 10.3171/2022.9.JNS221896.
    >> Share

  125. SUN GC, Shu XJ, Zheng XQ, Ma XD, et al
    The transfrontal isthmus approach for insular glioma surgery.
    J Neurosurg. 2022 Nov 11:1-9. doi: 10.3171/2022.8.JNS22923.
    >> Share

  126. RUZEVICK J, Cardinal T, Pangal DJ, Bove I, et al
    From white to blue light: evolution of endoscope-assisted intracranial tumor neurosurgery and expansion to intraaxial tumors.
    J Neurosurg. 2022 Nov 11:1-6. doi: 10.3171/2022.10.JNS22489.
    >> Share

  127. PARK YW, Han K, Park JE, Ahn SS, et al
    Leptomeningeal metastases in glioma revisited: incidence and molecular predictors based on postcontrast fluid-attenuated inversion recovery imaging.
    J Neurosurg. 2022 Nov 4:1-11. doi: 10.3171/2022.9.JNS221659.
    >> Share

  128. HAJTOVIC S, Sun J, Multani JS, Herrmann LL, et al
    Surgical cytoreduction of deep-seated high-grade glioma through tubular retractor.
    J Neurosurg. 2022 Nov 4:1-12. doi: 10.3171/2022.9.JNS22842.
    >> Share

  129. REN L, Cheng H, Chen J, Deng J, et al
    Progesterone receptor expression and prediction of benefits of adjuvant radiotherapy in de novo atypical meningiomas after gross-total resection.
    J Neurosurg. 2022 Nov 4:1-10. doi: 10.3171/2022.9.JNS221530.
    >> Share

  130. YOUNG JS, Al-Adli N, Sibih YE, Scotford KL, et al
    Recognizing the psychological impact of a glioma diagnosis on mental and behavioral health: a systematic review of what neurosurgeons need to know.
    J Neurosurg. 2022 Nov 4:1-9. doi: 10.3171/2022.9.JNS221139.
    >> Share

    October 2022
  131. DIJKSTRA BM, Nonnekens J, Nagengast W, Kruijff S, et al
    Feasibility of bevacizumab-IRDye800CW as a tracer for fluorescence-guided meningioma surgery.
    J Neurosurg. 2022 Oct 28:1-10. doi: 10.3171/2022.9.JNS221036.
    >> Share

  132. YOMO S, Oda K, Oguchi K
    Effectiveness of immune checkpoint inhibitors in combination with stereotactic radiosurgery for patients with brain metastases from renal cell carcinoma: inverse probability of treatment weighting using propensity scores.
    J Neurosurg. 2022 Oct 28:1-9. doi: 10.3171/2022.9.JNS221215.
    >> Share

  133. RIBEIRO L, Ng S, Duffau H
    Recurrent insular low-grade gliomas: factors guiding the decision to reoperate.
    J Neurosurg. 2022 Oct 28:1-11. doi: 10.3171/2022.9.JNS221286.
    >> Share

  134. ZHANG Y, Tan H, Jia L, He J, et al
    Association of preoperative glucose concentration with mortality in patients undergoing craniotomy for brain tumor.
    J Neurosurg. 2022 Oct 28:1-9. doi: 10.3171/2022.9.JNS221251.
    >> Share

  135. NG S, Deverdun J, Lemaitre AL, Giampiccolo D, et al
    Precuneal gliomas promote behaviorally relevant remodeling of the functional connectome.
    J Neurosurg. 2022 Oct 28:1-11. doi: 10.3171/2022.9.JNS221723.
    >> Share

  136. TEWARIE IA, Senko AW, Jessurun CAC, Zhang AT, et al
    Predicting leptomeningeal disease spread after resection of brain metastases using machine learning.
    J Neurosurg. 2022 Oct 21:1-9. doi: 10.3171/2022.8.JNS22744.
    >> Share

  137. LAIGLE-DONADEY F, Metellus P, Guyotat J, Menei P, et al
    Surgery for glioblastomas in the elderly: an Association des Neuro-oncologues d'Expression Francaise (ANOCEF) trial.
    J Neurosurg. 2022 Oct 14:1-7. doi: 10.3171/2022.8.JNS221068.
    >> Share

  138. ZHANG X, Zhang G, Wang Y, Huang H, et al
    Alteration of default mode network: association with executive dysfunction in frontal glioma patients.
    J Neurosurg. 2022 Oct 14:1-10. doi: 10.3171/2022.8.JNS22591.
    >> Share

  139. ZHANG JJY, Lee KS, Wang DD, Hervey-Jumper SL, et al
    Seizure outcome after resection of insular glioma: a systematic review, meta-analysis, and institutional experience.
    J Neurosurg. 2022 Oct 14:1-12. doi: 10.3171/2022.8.JNS221067.
    >> Share

  140. TROUDE L, Avinens V, Farah K, Boucekine M, et al
    Surgical management of large cerebellopontine angle meningiomas: long-term results of a less aggressive resection strategy.
    J Neurosurg. 2022 Oct 7:1-10. doi: 10.3171/2022.8.JNS221329.
    >> Share

  141. LEE EJ, Chung HT, Park H, Kim JW, et al
    Factors associated with radiation toxicity and long-term tumor control more than 10 years after Gamma Knife surgery for non-skull base, nonperioptic benign supratentorial meningiomas.
    J Neurosurg. 2022 Oct 7:1-11. doi: 10.3171/2022.8.JNS22422.
    >> Share

  142. NAIR SK, Botros D, Chakravarti S, Mao Y, et al
    Predictors of surgical site infection in glioblastoma patients undergoing craniotomy for tumor resection.
    J Neurosurg. 2022 Oct 7:1-8. doi: 10.3171/2022.8.JNS212799.
    >> Share

    September 2022
  143. HENDERSON F, Youngerman BE, Niogi SN, Alexander T, et al
    Endonasal transsphenoidal surgery for planum sphenoidale versus tuberculum sellae meningiomas.
    J Neurosurg. 2022 Sep 30:1-9. doi: 10.3171/2022.8.JNS22632.
    >> Share

  144. CHEN CH, Wei KC, Liao WC, Lin YY, et al
    Prognostic value of an APOBEC3 deletion polymorphism for glioma patients in Taiwan.
    J Neurosurg. 2022 Sep 23:1-13. doi: 10.3171/2022.7.JNS2250.
    >> Share

  145. YAMADA S, Hirayama R, Iwata T, Kuroda H, et al
    Growth risk classification and typical growth speed of convexity, parasagittal, and falx meningiomas: a retrospective cohort study.
    J Neurosurg. 2022 Sep 16:1-7. doi: 10.3171/2022.8.JNS221290.
    >> Share

  146. HOSMANN A, Jaber M, Roetzer-Pejrimovsky T, Timelthaler G, et al
    CD34 microvascularity in low-grade glioma: correlation with 5-aminolevulinic acid fluorescence and patient prognosis in a multicenter study at three specialized centers.
    J Neurosurg. 2022 Sep 16:1-10. doi: 10.3171/2022.7.JNS22921.
    >> Share

  147. MAIER AD, Meddis A, Mirian C, Haslund-Vinding J, et al
    Gene expression analysis during progression of malignant meningioma compared to benign meningioma.
    J Neurosurg. 2022 Sep 16:1-11. doi: 10.3171/2022.7.JNS22585.
    >> Share

  148. LEHRER EJ, Ahluwalia MS, Gurewitz J, Bernstein K, et al
    Imaging-defined necrosis after treatment with single-fraction stereotactic radiosurgery and immune checkpoint inhibitors and its potential association with improved outcomes in patients with brain metastases: an international multicenter study of 697
    J Neurosurg. 2022 Sep 16:1-10. doi: 10.3171/2022.7.JNS22752.
    >> Share

  149. ZHAO B, Xing H, Xia Y, Ma W, et al
    Letter to the Editor. Supramaximal resection for newly diagnosed eloquent glioblastoma.
    J Neurosurg. 2022 Sep 16:1-2. doi: 10.3171/2022.6.JNS221338.
    >> Share

  150. HANNA GK, Madany M, Tay ASS, Edwards LA, et al
    ZEB1 loss increases glioma stem cell tumorigenicity and resistance to chemoradiation.
    J Neurosurg. 2022 Sep 16:1-12. doi: 10.3171/2022.7.JNS22259.
    >> Share

  151. HIMES BT, Fain CE, Tritz ZP, Nesvick CL, et al
    Use of heparin to rescue immunosuppressive monocyte reprogramming by glioblastoma-derived extracellular vesicles.
    J Neurosurg. 2022 Sep 16:1-11. doi: 10.3171/2022.6.JNS2274.
    >> Share

    August 2022
  152. PEREIRA BJA, Marcondes Lerario A, Sola PR, Laurentino TS, et al
    Impact of a cell cycle and an extracellular matrix remodeling transcriptional signature on tumor progression and correlation with EZH2 expression in meningioma.
    J Neurosurg. 2022 Aug 26:1-14. doi: 10.3171/2022.7.JNS22953.
    >> Share

  153. PARK J, Sim J, Ahn J, Kim YJ, et al
    Molecular characteristics of incidental lower-grade glioma for treatment decision-making.
    J Neurosurg. 2022 Aug 19:1-10. doi: 10.3171/2022.6.JNS22967.
    >> Share

  154. ROH H, Lee SY, Lee J, Hwang SY, et al
    Use of thyroid transcription factor 1 and napsin A to predict local failure and survival after Gamma Knife radiosurgery in patients with brain metastases from lung adenocarcinoma.
    J Neurosurg. 2022 Aug 12:1-11. doi: 10.3171/2022.6.JNS22450.
    >> Share

  155. WANG Y, Sakaguchi M, Sabit H, Tamai S, et al
    COL1A2 inhibition suppresses glioblastoma cell proliferation and invasion.
    J Neurosurg. 2022 Aug 5:1-10. doi: 10.3171/2022.6.JNS22319.
    >> Share

    July 2022
  156. GAO S, Jin L, Moliterno J, Corbin ZA, et al
    Impact of radiotherapy delay following biopsy for patients with unresected glioblastoma.
    J Neurosurg. 2022 Jul 29:1-11. doi: 10.3171/2022.5.JNS212761.
    >> Share

  157. KIM YJ, Moon KS, Jang WY, Jung TY, et al
    Contralateral subfrontal approach for tuberculum sellae meningioma: techniques and clinical outcomes.
    J Neurosurg. 2022 Jul 22:1-12. doi: 10.3171/2022.5.JNS212899.
    >> Share

  158. PITSKHELAURI D, Sufianov R, Konovalov A, Pronin I, et al
    Median trans-atlanto-occipital membrane microsurgical approach to the posterior cranial fossa without craniotomy.
    J Neurosurg. 2022 Jul 22:1-8. doi: 10.3171/2022.5.JNS22111.
    >> Share

  159. SOLARI D, d'Avella E, Agresta G, Catapano D, et al
    Endoscopic endonasal approach for infradiaphragmatic craniopharyngiomas: a multicentric Italian study.
    J Neurosurg. 2022 Jul 8:1-11. doi: 10.3171/2022.5.JNS212974.
    >> Share

  160. ABRAMOV I, Park MT, Belykh E, Dru AB, et al
    Intraoperative confocal laser endomicroscopy: prospective in vivo feasibility study of a clinical-grade system for brain tumors.
    J Neurosurg. 2022 Jul 8:1-11. doi: 10.3171/2022.5.JNS2282.
    >> Share

    June 2022
  161. YU ZY, Chung MH, Wang PW, Wu YC, et al
    Letter to the Editor. Prediction model of IDH wild-type glioblastoma.
    J Neurosurg. 2022;137:1200.
    >> Share

  162. NGUYEN MP, Morshed RA, Dalle Ore CL, Cummins DD, et al
    Supervised machine learning algorithms demonstrate proliferation index correlates with long-term recurrence after complete resection of WHO grade I meningioma.
    J Neurosurg. 2022 Jun 3:1-9. doi: 10.3171/2022.4.JNS212516.
    >> Share

    May 2022
  163. CHOTAI S, Tang AR, McDermott JR, Guidry BS, et al
    Comparison of supratentorial meningioma resection outcomes by dural reconstruction technique.
    J Neurosurg. 2022 May 27:1-8. doi: 10.3171/2022.4.JNS22290.
    >> Share

  164. YU ZY, Chung MH, Wang PW, Wu YC, et al
    Letter to the Editor. Outcome of malignant meningioma.
    J Neurosurg. 2022 May 27:1. doi: 10.3171/2022.3.JNS22645.
    >> Share

  165. NICHOLS NM, Hadjipanayis CG
    Editorial. Supramaximal resection of eloquent glioblastoma: a continued paradigm shift in neurosurgical oncology.
    J Neurosurg. 2022 May 27:1-3. doi: 10.3171/2022.3.JNS22564.
    >> Share

  166. DI L, Shah AH, Mahavadi A, Eichberg DG, et al
    Radical supramaximal resection for newly diagnosed left-sided eloquent glioblastoma: safety and improved survival over gross-total resection.
    J Neurosurg. 2022 May 27:1-8. doi: 10.3171/2022.3.JNS212399.
    >> Share

  167. HASEGAWA H, Inoue A, Helal A, Kashiwabara K, et al
    Pineal cyst: results of long-term MRI surveillance and analysis of growth and shrinkage rates.
    J Neurosurg. 2022 May 27:1-7. doi: 10.3171/2022.4.JNS22276.
    >> Share

  168. SNEED PK, Chan JW, Ma L, Braunstein SE, et al
    Adverse radiation effect and freedom from progression following repeat stereotactic radiosurgery for brain metastases.
    J Neurosurg. 2022 May 20:1-9. doi: 10.3171/2022.4.JNS212597.
    >> Share

  169. TANJI M, Mineharu Y, Sakata A, Okuchi S, et al
    High intratumoral susceptibility signal grade on susceptibility-weighted imaging: a risk factor for hemorrhage after stereotactic biopsy.
    J Neurosurg. 2022 May 13:1-8. doi: 10.3171/2022.4.JNS212505.
    >> Share

    April 2022
  170. BETTAG C, Hussein A, Schatlo B, Barrantes-Freer A, et al
    Endoscope-assisted visualization of 5-aminolevulinic acid fluorescence in surgery for brain metastases.
    J Neurosurg. 2022 Apr 29:1-6. doi: 10.3171/2022.3.JNS212301.
    >> Share

  171. GARCIA JH, Morshed RA, Chung J, Millares Chavez MA, et al
    Factors associated with preoperative and postoperative seizures in patients undergoing resection of brain metastases.
    J Neurosurg. 2022 Apr 29:1-8. doi: 10.3171/2022.3.JNS212285.
    >> Share

  172. THOMANN P, Hani L, Vulcu S, Schutz A, et al
    Natural history of meningiomas: a serial volumetric analysis of 240 tumors.
    J Neurosurg. 2022 Apr 29:1-11. doi: 10.3171/2022.3.JNS212626.
    >> Share

  173. LARKIN CJ, Yerneni K, Karras CL, Abecassis ZA, et al
    Impact of intraoperative direct cortical stimulation dynamics on perioperative seizures and afterdischarge frequency in patients undergoing awake craniotomy.
    J Neurosurg. 2022 Apr 29:1-9. doi: 10.3171/2022.
    >> Share

  174. PARK HH, Yoo J, Oh HC, Cha YJ, et al
    Regrowth factors of WHO grade I skull base meningiomas following incomplete resection.
    J Neurosurg. 2022 Apr 22:1-10. doi: 10.3171/2022.3.JNS2299.
    >> Share

  175. CHO A, Medvedeva K, Kranawetter B, Untersteiner H, et al
    How to dose-stage large or high-risk brain metastases: an alternative two-fraction radiosurgical treatment approach.
    J Neurosurg. 2022 Apr 15:1-10. doi: 10.3171/2022.2.JNS212440.
    >> Share

  176. WANG Y, Pan C, Xie M, Zuo P, et al
    Adult diffuse intrinsic pontine glioma: clinical, radiological, pathological, molecular features, and treatments of 96 patients.
    J Neurosurg. 2022 Apr 8:1-11. doi: 10.3171/2022.2.JNS211920.
    >> Share

  177. KIM AA, Dono A, Khalafallah AM, Nettel-Rueda B, et al
    Early repeat resection for residual glioblastoma: decision-making among an international cohort of neurosurgeons.
    J Neurosurg. 2022 Apr 1:1-10. doi: 10.3171/2022.1.JNS211970.
    >> Share

  178. GOEL A, Shah A, Vutha R
    Letter to the Editor. En masse resection of gliomas.
    J Neurosurg. 2022 Apr 1:1-2. doi: 10.3171/2022.1.JNS22107.
    >> Share

  179. CASTRO MRH, Magill ST, Morshed RA, Young JS, et al
    Facial pain and sensory outcomes following resection of tumors compressing the trigeminal nerve.
    J Neurosurg. 2021;136:1119-1127.
    >> Share

  180. KINOSHITA Y, Zomorodi AR, Friedman AH, Sato H, et al
    Retrolabyrinthine transsigmoid approach to complex parabrainstem tumors in the posterior fossa.
    J Neurosurg. 2021;136:1097-1102.
    >> Share

  181. HUNDLEY KN, Pait TG, Rodriguez A, Day JD, et al
    Dr. Louise Eisenhardt's personal notes: how she and Dr. Cushing collected data and followed patients.
    J Neurosurg. 2021;136:1173-1178.
    >> Share

  182. ROSENSTOCK T, Hani L, Grittner U, Schlinkmann N, et al
    Bicentric validation of the navigated transcranial magnetic stimulation motor risk stratification model.
    J Neurosurg. 2021;136:1194-1206.
    >> Share

    March 2022
  183. STRICKLAND BA, Wedemeyer M, Ruzevick J, Micko A, et al
    5-Aminolevulinic acid-enhanced fluorescence-guided treatment of high-grade glioma using angled endoscopic blue light visualization: technical case series with preliminary follow-up.
    J Neurosurg. 2022 Mar 18:1-9. doi: 10.3171/2022.1.JNS212562.
    >> Share

  184. KIM KM, Kim SM, Kang H, Ji SY, et al
    Preservation of language function by mapping the arcuate fasciculus using intraoperative corticocortical evoked potential under general anesthesia in glioma surgery.
    J Neurosurg. 2022 Mar 18:1-9. doi: 10.3171/2022.1.JNS212658.
    >> Share

  185. DE SWART ME, Muller DMJ, Ardon H, Balvers RK, et al
    Between-hospital variation in time to glioblastoma surgery: a report from the Quality Registry Neuro Surgery in the Netherlands.
    J Neurosurg. 2022 Mar 11:1-10. doi: 10.3171/2022.1.JNS212566.
    >> Share

  186. MAIER AD, Mirian C, Haslund-Vinding J, Bartek J, et al
    Granular clinical history and outcome in 51 patients with primary and secondary malignant meningioma.
    J Neurosurg. 2022 Mar 11:1-11. doi: 10.3171/2022.1.JNS212723.
    >> Share

  187. JIMENEZ AE, Cicalese KV, Chakravarti S, Porras JL, et al
    Social determinants of health and the prediction of 90-day mortality among brain tumor patients.
    J Neurosurg. 2022 Mar 11:1-9. doi: 10.3171/2022.1.JNS212829.
    >> Share

  188. JAKOLA AS, Pedersen LK, Skjulsvik AJ, Myrmel K, et al
    The impact of resection in IDH-mutant WHO grade 2 gliomas: a retrospective population-based parallel cohort study.
    J Neurosurg. 2022 Mar 4:1-8. doi: 10.3171/2022.1.JNS212514.
    >> Share

  189. MRAH S, Descoteaux M, Wager M, Bore A, et al
    Network-level prediction of set-shifting deterioration after lower-grade glioma resection.
    J Neurosurg. 2022 Mar 4:1-9. doi: 10.3171/2022.1.JNS212257.
    >> Share

  190. POMERANIEC IJ, Xu Z, Lee CC, Yang HC, et al
    Dose to neuroanatomical structures surrounding pituitary adenomas and the effect of stereotactic radiosurgery on neuroendocrine function: an international multicenter study.
    J Neurosurg. 2021;136:813-821.
    >> Share

  191. CEYLAN S, Sen HE, Ozsoy B, Ceylan EC, et al
    Endoscopic approach for giant pituitary adenoma: clinical outcomes of 205 patients and comparison of two proposed classification systems for preoperative prediction of extent of resection.
    J Neurosurg. 2021;136:786-800.
    >> Share

  192. LABIB MA, Zhao X, Houlihan LM, Abramov I, et al
    Comparative analysis of the combined petrosal and the pretemporal transcavernous anterior petrosal approach to the petroclival region.
    J Neurosurg. 2021;136:905-916.
    >> Share

  193. RICHE M, Marijon P, Amelot A, Bielle F, et al
    Severity, timeline, and management of complications after stereotactic brain biopsy.
    J Neurosurg. 2021;136:867-876.
    >> Share

  194. MATHIEU D, Kotecha R, Sahgal A, De Salles A, et al
    Stereotactic radiosurgery for secretory pituitary adenomas: systematic review and International Stereotactic Radiosurgery Society practice recommendations.
    J Neurosurg. 2021;136:801-812.
    >> Share

    February 2022
  195. SUERO MOLINA E, Black D, Kaneko S, Muther M, et al
    Double dose of 5-aminolevulinic acid and its effect on protoporphyrin IX accumulation in low-grade glioma.
    J Neurosurg. 2022 Feb 25:1-10. doi: 10.3171/2021.12.JNS211724.
    >> Share

  196. MATSUNAGA S, Shuto T, Serizawa T, Aoyagi K, et al
    Gamma Knife radiosurgery for metastatic brain tumors from ovarian cancer: histopathological analysis of survival and local control. A Japanese multi-institutional cooperative and retrospective cohort study.
    J Neurosurg. 2022 Feb 11:1-9. doi: 10.3171/2021.12.JNS212239.
    >> Share

  197. CHO A, Hennenberg J, Untersteiner H, Hirschmann D, et al
    Influence of temporal muscle thickness on the outcome of radiosurgically treated patients with brain metastases from non-small cell lung cancer.
    J Neurosurg. 2022 Feb 4:1-7. doi: 10.3171/2021.12.JNS212193.
    >> Share

  198. LEE WJ, Hong SD, Woo KI, Seol HJ, et al
    Endoscopic endonasal and transorbital approaches to petrous apex lesions.
    J Neurosurg. 2021;136:431-440.
    >> Share

  199. TOMIO R, Horiguchi T, Borghei-Razavi H, Tamura R, et al
    Anterior transpetrosal approach: experiences in 274 cases over 33 years. Technical variations, operated patients, and approach-related complications.
    J Neurosurg. 2021;136:413-421.
    >> Share

  200. ZHANG JJ, Liu YH, Tu MY, Wei K, et al
    Comparison of 1.0 g/kg of 20% mannitol initiated at different time points and effects on brain relaxation in patients with midline shift undergoing supratentorial tumor resection: a randomized controlled trial.
    J Neurosurg. 2021;136:350-357.
    >> Share

  201. ASHER AL, Khalafallah AM, Mukherjee D, Alvi MA, et al
    Launching the Quality Outcomes Database Tumor Registry: rationale, development, and pilot data.
    J Neurosurg. 2021;136:369-378.
    >> Share

  202. HARDESTY DA, Montaser A, Kreatsoulas D, Shah VS, et al
    Complications after 1002 endoscopic endonasal approach procedures at a single center: lessons learned, 2010-2018.
    J Neurosurg. 2021;136:393-404.
    >> Share

  203. SNYDER MH, Asuzu DT, Shaver DE, Vance ML, et al
    Routine postoperative fluid restriction to prevent syndrome of inappropriate antidiuretic hormone secretion after transsphenoidal resection of pituitary adenoma.
    J Neurosurg. 2021;136:405-412.
    >> Share

    January 2022
  204. CHEN WC, Lafreniere M, Phuong C, Liu SJ, et al
    Resection with intraoperative cesium-131 brachytherapy as salvage therapy for recurrent brain tumors.
    J Neurosurg. 2022 Jan 21:1-7. doi: 10.3171/2021.10.JNS211886.
    >> Share

  205. MATHIESEN T, Haslund-Vinding J, Skjoth-Rasmussen J, Poulsgaard L, et al
    Letter to the Editor. Copenhagen grading of meningioma.
    J Neurosurg. 2022 Jan 21:1-3. doi: 10.3171/2021.10.JNS204467.
    >> Share

  206. CASTLE-KIRSZBAUM M, Kam J, Dixon B, Goldschlager T, et al
    Surgical outcomes and longitudinal quality of life after endoscopic endonasal surgery for anterior skull base meningioma.
    J Neurosurg. 2022 Jan 14:1-8. doi: 10.3171/2021.11.JNS212090.
    >> Share

  207. MIJDERWIJK HJ, Nieboer D, Incekara F, Berger K, et al
    Development and external validation of a clinical prediction model for survival in patients with IDH wild-type glioblastoma.
    J Neurosurg. 2022 Jan 14:1-10. doi: 10.3171/2021.10.JNS211261.
    >> Share

  208. AL-HOLOU WN, Suki D, Hodges TR, Everson RG, et al
    Circumferential sulcus-guided resection technique for improved outcomes of low-grade gliomas.
    J Neurosurg. 2022 Jan 7:1-11. doi: 10.3171/2021.9.JNS21718.
    >> Share

  209. BROWN DA, Goyal A, Richter KR, Haglin JM, et al
    Clinical utility of brain biopsy for presumed CNS relapse of systemic lymphoma.
    J Neurosurg. 2021;136:30-39.
    >> Share

    December 2021
  210. YOO J, Yoon SJ, Kim KH, Jung IH, et al
    Patterns of recurrence according to the extent of resection in patients with IDH-wild-type glioblastoma: a retrospective study.
    J Neurosurg. 2021 Dec 31:1-11. doi: 10.3171/2021.10.JNS211491.
    >> Share

  211. BENJAMIN CG, Gurewitz J, Kavi A, Bernstein K, et al
    Survival and outcomes in patients with >/= 25 cumulative brain metastases treated with stereotactic radiosurgery.
    J Neurosurg. 2021 Dec 24:1-11. doi: 10.3171/2021.9.JNS21882.
    >> Share

  212. CHIOU GY, Chiang CL, Yang HC, Shen CI, et al
    Combined stereotactic radiosurgery and tyrosine kinase inhibitor therapy versus tyrosine kinase inhibitor therapy alone for the treatment of non-small cell lung cancer patients with brain metastases.
    J Neurosurg. 2021 Dec 17:1-8. doi: 10.3171/2021.9.JNS211373.
    >> Share

  213. YOMO S, Yako T, Kitazawa K, Oguchi K, et al
    Staged radiosurgery alone versus postoperative cavity radiosurgery for patients with midsize-to-large brain metastases: a propensity score matching analysis.
    J Neurosurg. 2021 Dec 17:1-8. doi: 10.3171/2021.9.JNS211797.
    >> Share

  214. SHIBAHARA I, Saito R, Kanamori M, Sonoda Y, et al
    Role of the parietooccipital fissure and its implications in the pathophysiology of posterior medial temporal gliomas.
    J Neurosurg. 2021 Dec 14:1-10. doi: 10.3171/2021.7.JNS21990.
    >> Share

  215. LONDON D, Patel DN, Donahue B, Navarro RE, et al
    The incidence and predictors of new brain metastases in patients with non-small cell lung cancer following discontinuation of systemic therapy.
    J Neurosurg. 2021 Dec 10:1-11. doi: 10.3171/2021.9.JNS212150.
    >> Share

  216. GADOT R, Khan AB, Patel R, Goethe E, et al
    Predictors of postoperative seizure outcome in supratentorial meningioma.
    J Neurosurg. 2021 Dec 10:1-10. doi: 10.3171/2021.9.JNS211738.
    >> Share

    November 2021
  217. MORSHED RA, Lee AT, Wang EJ, Young JS, et al
    Functional outcomes after resection of middle frontal gyrus diffuse gliomas.
    J Neurosurg. 2021 Nov 19:1-8. doi: 10.3171/2021.8.JNS211624.
    >> Share

  218. RAMOS-FRESNEDO A, Domingo RA, Sanchez-Garavito JE, Perez-Vega C, et al
    The impact of multiple lesions on progression-free survival of meningiomas: a 10-year multicenter experience.
    J Neurosurg. 2021 Nov 19:1-9. doi: 10.3171/2021.8.JNS211252.
    >> Share

  219. GOYAL A, Zreik J, Brown DA, Kerezoudis P, et al
    Disparities in access to surgery for glioblastoma multiforme at high-volume Commission on Cancer-accredited hospitals in the United States.
    J Neurosurg. 2021 Nov 12:1-10. doi: 10.3171/2021.7.JNS211307.
    >> Share

  220. BUNEVICIUS A, Pikis S, Kondziolka D, Patel DN, et al
    Stereotactic radiosurgery for glioblastoma considering tumor genetic profiles: an international multicenter study.
    J Neurosurg. 2021 Nov 5:1-9. doi: 10.3171/2021.7.JNS211277.
    >> Share

  221. MATHON B, Amelot A
    Letter to the Editor. The place of brain biopsy in patients with presumed CNS relapse of systemic lymphoma.
    J Neurosurg. 2021;136:933-934.
    >> Share

    October 2021
  222. AVERY MB, Mallari RJ, Barkhoudarian G, Kelly DF, et al
    Supraorbital and mini-pterional keyhole craniotomies for brain tumors: a clinical and anatomical comparison of indications and outcomes in 204 cases.
    J Neurosurg. 2021 Oct 29:1-11. doi: 10.3171/2021.6.JNS21759.
    >> Share

  223. TRIPATHI S, Vivas-Buitrago T, Domingo RA, Biase G, et al
    IDH-wild-type glioblastoma cell density and infiltration distribution influence on supramarginal resection and its impact on overall survival: a mathematical model.
    J Neurosurg. 2021 Oct 29:1-9. doi: 10.3171/2021.6.JNS21925.
    >> Share

  224. JUNGER ST, Reinecke D, Meissner AK, Goldbrunner R, et al
    Resection of symptomatic non-small cell lung cancer brain metastasis in the setting of multiple brain metastases.
    J Neurosurg. 2021 Oct 29:1-7. doi: 10.3171/2021.7.JNS211172.
    >> Share

  225. WADIURA LI, Reichert D, Sperl V, Lang A, et al
    Influence of dexamethasone on visible 5-ALA fluorescence and quantitative protoporphyrin IX accumulation measured by fluorescence lifetime imaging in glioblastomas: is pretreatment obligatory before fluorescence-guided surgery?
    J Neurosurg. 2021 Oct 22:1-9. doi: 10.3171/2021.6.JNS21940.
    >> Share

  226. KHALAFALLAH AM, Rakovec M, Burapachaisri K, Fung S, et al
    The Suprasellar Meningioma Patient-Reported Outcome Survey: a disease-specific patient-reported outcome measure for resection of suprasellar meningioma.
    J Neurosurg. 2021;:9.
    >> Share

  227. GODIL SS, Tosi U, Gerges M, Garton ALA, et al
    Long-term tumor control after endoscopic endonasal resection of craniopharyngiomas: comparison of gross-total resection versus subtotal resection with radiation therapy.
    J Neurosurg. 2021 Oct 15:1-9. doi: 10.3171/2021.5.JNS202011.
    >> Share

  228. MOMIN AA, Soni P, Shao J, Nowacki AS, et al
    Adjuvant radiation versus observation with salvage radiation after gross-total resection of WHO grade II meningiomas: a propensity score-adjusted analysis.
    J Neurosurg. 2021 Oct 8:1-8. doi: 10.3171/2021.4.JNS21559.
    >> Share

  229. SCHUPPER AJ, Baron RB, Cheung W, Rodriguez J, et al
    5-Aminolevulinic acid for enhanced surgical visualization of high-grade gliomas: a prospective, multicenter study.
    J Neurosurg. 2021 Oct 8:1-10. doi: 10.3171/2021.5.JNS21310.
    >> Share

  230. POPADIC B, Scheichel F, Pinggera D, Weber M, et al
    The meningioma surface factor: a novel approach to quantify shape irregularity on preoperative imaging and its correlation with WHO grade.
    J Neurosurg. 2021 Oct 8:1-7. doi: 10.3171/2021.5.JNS204223.
    >> Share

  231. DUFFAU H
    Introducing the concept of brain metaplasticity in glioma: how to reorient the pattern of neural reconfiguration to optimize the therapeutic strategy.
    J Neurosurg. 2021 Oct 8:1-5. doi: 10.3171/2021.5.JNS211214.
    >> Share

  232. YOUNG JS, Gogos AJ, Aabedi AA, Morshed RA, et al
    Resection of supplementary motor area gliomas: revisiting supplementary motor syndrome and the role of the frontal aslant tract.
    J Neurosurg. 2021 Oct 1:1-7. doi: 10.3171/2021.4.JNS21187.
    >> Share

  233. FISHER FL, Zamanipoor Najafabadi AH, van der Meer PB, Boele FW, et al
    Long-term health-related quality of life and neurocognitive functioning after treatment in skull base meningioma patients.
    J Neurosurg. 2021 Oct 1:1-13. doi: 10.3171/2021.4.JNS203891.
    >> Share

    September 2021
  234. SAITO T, Muragaki Y, Tamura M, Maruyama T, et al
    Awake craniotomy with transcortical motor evoked potential monitoring for resection of gliomas within or close to motor-related areas: validation of utility for predicting motor function.
    J Neurosurg. 2021 Sep 24:1-10. doi: 10.3171/2021.3.JNS21374.
    >> Share

  235. MEDIKONDA R, Patel K, Jackson C, Saleh L, et al
    The safety and efficacy of dexamethasone in the perioperative management of glioma patients.
    J Neurosurg. 2021 Sep 24:1-8. doi: 10.3171/2021.4.JNS204127.
    >> Share

  236. ASUZU DT, Bunevicius A, Kormath Anand R, Suleiman M, et al
    Clinical and radiologic outcomes after stereotactic radiosurgery for meningiomas in direct contact with the optic apparatus: an international multicenter study.
    J Neurosurg. 2021 Sep 24:1-7. doi: 10.3171/2021.3.JNS21328.
    >> Share

  237. HAMDAN N, Duffau H
    Extending the multistage surgical strategy for recurrent initially low-grade gliomas: functional and oncological outcomes in 31 consecutive patients who underwent a third resection under awake mapping.
    J Neurosurg. 2021 Sep 10:1-10. doi: 10.3171/2021.3.JNS21264.
    >> Share

  238. CARNEVALE JA, Imber BS, Winston GM, Goldberg JL, et al
    Risk of tract recurrence with stereotactic biopsy of brain metastases: an 18-year cancer center experience.
    J Neurosurg. 2021 Sep 10:1-7. doi: 10.3171/2021.3.JNS204347.
    >> Share

    August 2021
  239. SHIMIZU Y, Gumin J, Gao F, Hossain A, et al
    Characterization of patient-derived bone marrow human mesenchymal stem cells as oncolytic virus carriers for the treatment of glioblastoma.
    J Neurosurg. 2021 Aug 27:1-11. doi: 10.3171/2021.3.JNS203045.
    >> Share

  240. MORSHED RA, Jiam NT, Wang EJ, Magill ST, et al
    Posterior petrous face meningiomas presenting with Meniere's-like syndrome: a case series and review of the literature.
    J Neurosurg. 2021 Aug 27:1-8. doi: 10.3171/2021.2.JNS203259.
    >> Share

  241. BENJAMIN CG, Schnurman Z, Ashayeri K, Kazi E, et al
    Volumetric growth rates of untreated cavernous sinus meningiomas.
    J Neurosurg. 2021 Aug 20:1-8. doi: 10.3171/2021.2.JNS203485.
    >> Share

  242. MEDIKONDA R, Choi J, Pant A, Saleh L, et al
    Synergy between glutamate modulation and anti-programmed cell death protein 1 immunotherapy for glioblastoma.
    J Neurosurg. 2021 Aug 13:1-10. doi: 10.3171/2021.1.JNS202482.
    >> Share

  243. SPINA A, Boari N, Mortini P
    Letter to the Editor. Management of hyperostotic spheno-orbital meningiomas.
    J Neurosurg. 2021 Aug 13:1-2. doi: 10.3171/2021.4.JNS21952.
    >> Share

  244. MICKO A, Agam MS, Brunswick A, Strickland BA, et al
    Treatment strategies for giant pituitary adenomas in the era of endoscopic transsphenoidal surgery: a multicenter series.
    J Neurosurg. 2021 Aug 13:1-10. doi: 10.3171/2021.1.JNS203982.
    >> Share

  245. CHUANG JM, Hueng DY
    Letter to the Editor. Treatment of MGMT-positive glioblastoma.
    J Neurosurg. 2021 Aug 6:1. doi: 10.3171/2021.3.JNS21571.
    >> Share

  246. ROMERO-GARCIA R, Suckling J, Owen M, Assem M, et al
    Memory recovery in relation to default mode network impairment and neurite density during brain tumor treatment.
    J Neurosurg. 2021 Aug 6:1-11. doi: 10.3171/2021.1.JNS203959.
    >> Share

    July 2021
  247. AMMANUEL SG, Almeida NC, Kurteff G, Kakaizada S, et al
    Correlation of natural language assessment results with health-related quality of life in adult glioma patients.
    J Neurosurg. 2021 Jul 30:1-7. doi: 10.3171/2021.1.JNS203387.
    >> Share

  248. LAD M, Gupta R, Raman A, Parikh N, et al
    Trends in physician reimbursements and procedural volumes for radiosurgery versus open surgery in brain tumor care: an analysis of Medicare data from 2009 to 2018.
    J Neurosurg. 2021 Jul 30:1-12. doi: 10.3171/2020.11.JNS202284.
    >> Share

  249. SILVA LL, Tuncer MS, Vajkoczy P, Picht T, et al
    Distinct approaches to language pathway tractography: comparison of anatomy-based, repetitive navigated transcranial magnetic stimulation (rTMS)-based, and rTMS-enhanced diffusion tensor imaging-fiber tracking.
    J Neurosurg. 2021 Jul 30:1-12. doi: 10.3171/2020.12.JNS204028.
    >> Share

  250. HAMIDI N, Karmur B, Sperrazza S, Alexieva J, et al
    Guidelines for optimal utilization of social media for brain tumor stakeholders.
    J Neurosurg. 2021 Jul 23:1-8. doi: 10.3171/2020.11.JNS203226.
    >> Share

  251. ULGEN E, Aras FK, Cosgun E, Ersen-Danyeli A, et al
    Correlation of anatomical involvement patterns of insular gliomas with subnetworks of the limbic system.
    J Neurosurg. 2021 Jul 23:1-12. doi: 10.3171/2020.12.JNS203652.
    >> Share

  252. ASANO K, Hasegawa S, Matsuzaka M, Ohkuma H, et al
    Brain tumor-related epilepsy and risk factors for metastatic brain tumors: analysis of 601 consecutive cases providing real-world data.
    J Neurosurg. 2021 Jul 16:1-12. doi: 10.3171/2020.11.JNS202873.
    >> Share

  253. NEMAN J, Franklin M, Madaj Z, Deshpande K, et al
    Use of predictive spatial modeling to reveal that primary cancers have distinct central nervous system topography patterns of brain metastasis.
    J Neurosurg. 2021 Jul 16:1-9. doi: 10.3171/2021.1.JNS203536.
    >> Share

  254. MULLER DMJ, Robe PA, Ardon H, Barkhof F, et al
    On the cutting edge of glioblastoma surgery: where neurosurgeons agree and disagree on surgical decisions.
    J Neurosurg. 2021 Jul 9:1-11. doi: 10.3171/2020.11.JNS202897.
    >> Share

  255. LI L, Fang S, Li G, Zhang K, et al
    Glioma-related epilepsy in patients with diffuse high-grade glioma after the 2016 WHO update: seizure characteristics, risk factors, and clinical outcomes.
    J Neurosurg. 2021 Jul 9:1-9. doi: 10.3171/2020.12.JNS203351.
    >> Share

  256. CHAN AY, Choi EH, Oh MY, Vadera S, et al
    Elective versus nonelective brain tumor resections: a 5-year propensity score matching cost comparison analysis.
    J Neurosurg. 2021 Jul 9:1-5. doi: 10.3171/2020.12.JNS203401.
    >> Share

    June 2021
  257. ROSSI M, Puglisi G, Conti Nibali M, Vigano L, et al
    Asleep or awake motor mapping for resection of perirolandic glioma in the nondominant hemisphere? Development and validation of a multimodal score to tailor the surgical strategy.
    J Neurosurg. 2021 Jun 18:1-14. doi: 10.3171/2020.11.JNS202715.
    >> Share

  258. MOHAMMED N, Hung YC, Xu Z, Chytka T, et al
    Neurofibromatosis type 2-associated meningiomas: an international multicenter study of outcomes after Gamma Knife stereotactic radiosurgery.
    J Neurosurg. 2021 Jun 18:1-6. doi: 10.3171/2020.12.JNS202814.
    >> Share

  259. KANEKO S, Suero Molina E, Sporns P, Schipmann S, et al
    Fluorescence real-time kinetics of protoporphyrin IX after 5-ALA administration in low-grade glioma.
    J Neurosurg. 2021 Jun 18:1-7. doi: 10.3171/2020.10.JNS202881.
    >> Share

  260. SHAH PP, Franke JL, Medikonda R, Jackson CM, et al
    Mutation status and postresection survival of patients with non-small cell lung cancer brain metastasis: implications of biomarker-driven therapy.
    J Neurosurg. 2021 Jun 4:1-11. doi: 10.3171/2020.10.JNS201787.
    >> Share

  261. DELLA PEPA GM, D'Alessandris QG, Burattini B, Quaranta D, et al
    Letter to the Editor. Exploring cognitive functions in low-grade glioma surgery.
    J Neurosurg. 2021 Jun 4:1-2. doi: 10.3171/2021.2.JNS21186.
    >> Share

  262. VIVAS-BUITRAGO T, Domingo RA, Tripathi S, De Biase G, et al
    Influence of supramarginal resection on survival outcomes after gross-total resection of IDH-wild-type glioblastoma.
    J Neurosurg. 2021 Jun 4:1-8. doi: 10.3171/2020.10.JNS203366.
    >> Share

    May 2021
  263. ROTH O'BRIEN DA, Kaye SM, Poppas PJ, Mahase SS, et al
    Time to administration of stereotactic radiosurgery to the cavity after surgery for brain metastases: a real-world analysis.
    J Neurosurg. 2021 May 28:1-11. doi: 10.3171/2020.10.JNS201934.
    >> Share

  264. BABA A, Saha A, McCradden MD, Boparai K, et al
    Development and validation of a patient-centered, meningioma-specific quality-of-life questionnaire.
    J Neurosurg. 2021 May 14:1-10. doi: 10.3171/2020.11.JNS201761.
    >> Share

  265. QIAO N, Yang X, Li C, Ma G, et al
    The predictive value of intraoperative visual evoked potential for visual outcome after extended endoscopic endonasal surgery for adult craniopharyngioma.
    J Neurosurg. 2021 May 7:1-11. doi: 10.3171/2020.10.JNS202779.
    >> Share

    March 2021
  266. FAN J, Liu Y, Pan J, Peng Y, et al
    Endoscopic endonasal versus transcranial surgery for primary resection of craniopharyngiomas based on a new QST classification system: a comparative series of 315 patients.
    J Neurosurg. 2021 Mar 5:1-12. doi: 10.3171/2020.7.JNS20257.
    >> Share

  267. MAGILL ST, Jane JA, Prevedello DM
    Editorial. Craniopharyngioma classification.
    J Neurosurg. 2021 Mar 5:1-3. doi: 10.3171/2020.8.JNS202666.
    >> Share

  268. FONSECA A, Solano P, Ramaswamy V, Tabori U, et al
    Ventricular size determination and management of ventriculomegaly and hydrocephalus in patients with diffuse intrinsic pontine glioma: an institutional experience.
    J Neurosurg. 2021 Mar 5:1-7. doi: 10.3171/2020.10.JNS203257.
    >> Share

  269. TENG CW, Cho SS, Singh Y, De Ravin E, et al
    Second window ICG predicts gross-total resection and progression-free survival during brain metastasis surgery.
    J Neurosurg. 2021 Mar 2:1-10. doi: 10.3171/2020.8.JNS201810.
    >> Share

    February 2021
  270. MORISAKO H, Ohata H, Shinde B, Nagahama A, et al
    Minimal anterior and posterior combined transpetrosal approach for large petroclival meningiomas.
    J Neurosurg. 2021 Feb 19:1-10. doi: 10.3171/2020.8.JNS202060.
    >> Share

  271. RAPOPORT BI, McDermott MW, Schwartz TH
    Letter to the Editor. Time to move beyond the Simpson scale in meningioma surgery.
    J Neurosurg. 2021 Feb 19:1-2. doi: 10.3171/2020.12.JNS204213.
    >> Share

    January 2021
  272. MAGILL ST, Nguyen MP, Aghi MK, Theodosopoulos PV, et al
    Postoperative diffusion-weighted imaging and neurological outcome after convexity meningioma resection.
    J Neurosurg. 2021 Jan 29:1-8. doi: 10.3171/2020.8.JNS193537.
    >> Share

  273. MOTOMURA K, Chalise L, Shimizu H, Yamaguchi J, et al
    Intraoperative seizure outcome of levetiracetam combined with perampanel therapy in patients with glioma undergoing awake brain surgery.
    J Neurosurg. 2021 Jan 22:1-10. doi: 10.3171/2020.8.JNS201400.
    >> Share

  274. YOUNG JS, Gogos AJ, Pereira MP, Morshed RA, et al
    Effects of ventricular entry on patient outcome during glioblastoma resection.
    J Neurosurg. 2021 Jan 8:1-9. doi: 10.3171/2020.7.JNS201362.
    >> Share

  275. BUNEVICIUS A, Suleiman M, Patel S, Martinez Alvarez R, et al
    Stereotactic radiosurgery for treatment of radiation-induced meningiomas: a multiinstitutional study.
    J Neurosurg. 2021 Jan 1:1-9. doi: 10.3171/2020.7.JNS202064.
    >> Share

    December 2020
  276. STOGBAUER L, Thomas C, Wagner A, Warneke N, et al
    Efficacy of decitabine in malignant meningioma cells: relation to promoter demethylation of distinct tumor suppressor and oncogenes and independence from TERT.
    J Neurosurg. 2020 Dec 11:1-10. doi: 10.3171/2020.7.JNS193097.
    >> Share

  277. KENNEDY WR, DeWees TA, Acharya S, Mahmood M, et al
    Internal dose escalation associated with increased local control for melanoma brain metastases treated with stereotactic radiosurgery.
    J Neurosurg. 2020 Dec 11:1-7. doi: 10.3171/2020.7.JNS192210.
    >> Share

  278. GUPTE TP, Li C, Jin L, Yalcin K, et al
    Clinical and genomic factors associated with seizures in meningiomas.
    J Neurosurg. 2020 Dec 4:1-10. doi: 10.3171/2020.7.JNS201042.
    >> Share

  279. NG S, Herbet G, Lemaitre AL, Cochereau J, et al
    Neuropsychological assessments before and after awake surgery for incidental low-grade gliomas.
    J Neurosurg. 2020 Dec 4:1-10. doi: 10.3171/2020.7.JNS201507.
    >> Share

    November 2020
  280. GOGOS AJ
    Erratum. Triple motor mapping: transcranial, bipolar, and monopolar mapping for supratentorial glioma resection adjacent to motor pathways.
    J Neurosurg. 2020 Nov 27:1. doi: 10.3171/2020.10.JNS193434.
    >> Share

  281. YOO DH, Sohn CH, Cho YD, Kang HS, et al
    Superselective pseudocontinuous arterial spin labeling in patients with meningioma: utility in prediction of feeding arteries and preoperative embolization feasibility.
    J Neurosurg. 2020 Nov 13:1-7. doi: 10.3171/2020.7.JNS201915.
    >> Share

  282. MIYOSHI K, Wada T, Uwano I, Sasaki M, et al
    Predicting the consistency of intracranial meningiomas using apparent diffusion coefficient maps derived from preoperative diffusion-weighted imaging.
    J Neurosurg. 2020 Nov 13:1-8. doi: 10.3171/2020.6.JNS20740.
    >> Share

    October 2020
  283. PRZYBYLOWSKI CJ, Hendricks BK, Frisoli FA, Zhao X, et al
    Prognostic value of the Simpson grading scale in modern meningioma surgery: Barrow Neurological Institute experience.
    J Neurosurg. 2020 Oct 23:1-9. doi: 10.3171/2020.6.JNS20374.
    >> Share

  284. CHICOINE MR, Yahanda AT, Dacey RG
    A tribute to the late Professor Donald Simpson, Australian neurosurgeon and namesake of the Simpson grading system for meningioma extent of resection.
    J Neurosurg. 2020 Oct 23:1-7. doi: 10.3171/2020.6.JNS201331.
    >> Share

  285. SHAH AS, Sylvester PT, Yahanda AT, Vellimana AK, et al
    Intraoperative MRI for newly diagnosed supratentorial glioblastoma: a multicenter-registry comparative study to conventional surgery.
    J Neurosurg. 2020 Oct 9:1-10. doi: 10.3171/2020.6.JNS19287.
    >> Share

  286. SELLIER A, Moritz-Gasser S, Lemaitre AL, Herbet G, et al
    Presence of a translator in the operating theater for awake mapping in foreign patients with low-grade glioma: a surgical experience based on 18 different native languages.
    J Neurosurg. 2020 Oct 9:1-9. doi: 10.3171/2020.6.JNS201071.
    >> Share

  287. GOGOS AJ, Young JS, Pereira MP, Morshed RA, et al
    Surgical management of incidentally discovered low-grade gliomas.
    J Neurosurg. 2020 Oct 2:1-8. doi: 10.3171/2020.6.JNS201296.
    >> Share

  288. LIVERMORE LJ, Isabelle M, Bell IM, Edgar O, et al
    Raman spectroscopy to differentiate between fresh tissue samples of glioma and normal brain: a comparison with 5-ALA-induced fluorescence-guided surgery.
    J Neurosurg. 2020 Oct 2:1-11. doi: 10.3171/2020.5.JNS20376.
    >> Share

    June 2020
  289. TAKAMI H, Khoshnood N, Bernstein M
    Preoperative factors associated with adverse events during awake craniotomy: analysis of 609 consecutive cases.
    J Neurosurg. 2020 Jun 26:1-9. doi: 10.3171/2020.4.JNS20378.
    >> Share

    May 2020
  290. YOUNG JS, Chan AK, Viner JA, Sankaran S, et al
    A Safe Transitions Pathway for post-craniotomy neurological surgery patients: high-value care that bypasses the intensive care unit.
    J Neurosurg. 2020 May 29:1-6. doi: 10.3171/2020.3.JNS192133.
    >> Share

    April 2020
  291. CARRION-PENAGOS J, Zeineddine HA, Polster SP, Girard R, et al
    Subclinical imaging changes in cerebral cavernous angiomas during prospective surveillance.
    J Neurosurg. 2020 Apr 3:1-8. doi: 10.3171/2020.1.JNS193479.
    >> Share

    March 2020
  292. LOHMANN S, Brix T, Varghese J, Warneke N, et al
    Development and validation of prediction scores for nosocomial infections, reoperations, and adverse events in the daily clinical setting of neurosurgical patients with cerebral and spinal tumors.
    J Neurosurg. 2020 Mar 20:1-11. doi: 10.3171/2020.1.JNS193186.
    >> Share

    February 2020
  293. RUTLAND JW, Loewenstern J, Ranti D, Tsankova NM, et al
    Analysis of 7-tesla diffusion-weighted imaging in the prediction of pituitary macroadenoma consistency.
    J Neurosurg. 2020 Feb 28:1-9. doi: 10.3171/2019.12.JNS192940.
    >> Share

  294. ALHILALI LM, Little AS, Yuen KCJ, Lee J, et al
    Early postoperative MRI and detection of residual adenoma after transsphenoidal pituitary surgery.
    J Neurosurg. 2020 Feb 7:1-10. doi: 10.3171/2019.11.JNS191845.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016